Cargando…

Rhabdomyolysis after recombinant zoster vaccination: a rare adverse reaction

We present a case report describing a potential rare adverse reaction of the recombinant zoster vaccination. This patient is a 60-year-old female who was admitted for severe rhabdomyolysis after receiving the vaccine. The patient’s symptoms and CPK improved with aggressive hydration over several day...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajaratnam, Nishan, Govil, Swati, Patel, Rutwik, Ahmed, Mohamed, Elias, Sameh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850438/ https://www.ncbi.nlm.nih.gov/pubmed/33552439 http://dx.doi.org/10.1080/20009666.2020.1841878

Ejemplares similares

Organizing Pneumonia Following Recombinant Zoster Vaccination: A Rare Adverse Reaction
por: Khawaja, Imran, et al.
Publicado: (2022)

THE USE OF TOCILIZUMAB AT A COMMUNITY HOSPITAL DURING THE COVID-19 PANDEMIC IN THE EPICENTER OF NORTHERN NEW JERSEY
por: Capo, Aida, et al.
Publicado: (2020)

Rhabdomyolysis: A Rare Adverse Effect of Levetiracetam
por: Rastogi, Vaibhav, et al.
Publicado: (2018)

Preventing Varicella-Zoster: Advances With the Recombinant Zoster Vaccine
por: Ilyas, Sahrish, et al.
Publicado: (2020)

Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination
por: Bruxvoort, Katia J, et al.
Publicado: (2022)

Drug-Induced Liver Injury: A Unique Presentation of Single-Dose Administration of Propylthiouracil
por: Weissman, Simcha, et al.
Publicado: (2020)

A Rare Adverse Event of Rhabdomyolysis Caused by Sacubitril/Valsartan
por: Rawla, Prashanth, et al.
Publicado: (2019)

20. Cost-Effectiveness of Recombinant Zoster Vaccine for Vaccinating Immunocompromised Adults Against Herpes Zoster in the United States
por: Curran, Desmond, et al.
Publicado: (2021)

Healthy ageing: Herpes zoster infection and the role of the adjuvanted recombinant zoster vaccine
por: Curran, D, et al.
Publicado: (2022)

Uveitis reactivation following recombinant zoster vaccination
por: Richards, Paige J., et al.
Publicado: (2021)

Dermatomyositis-Induced Rhabdomyolysis With Features of Necrotizing Myopathy and Acute Inflammatory Demyelinating Polyneuropathy in an Epstein-Barr Virus Infected Patient
por: Haikal, Ammar, et al.
Publicado: (2020)

MRI Findings in Case of Post–COVID-19 Vaccination Rhabdomyolysis: A Rare Postvaccination Adverse Effect
por: Kalekar, Tushar M., et al.
Publicado: (2022)

Transfusion-related acute lung injury in a COVID-19–positive convalescent plasma recipient: a case report
por: Amrutiya, Viralkumar, et al.
Publicado: (2021)

Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals
por: Curran, Desmond, et al.
Publicado: (2020)

Estimated Public Health Impact of the Recombinant Zoster Vaccine
por: Patterson, Brandon J., et al.
Publicado: (2021)

Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer
por: Curran, Desmond, et al.
Publicado: (2023)

Acute Dystonia With Rhabdomyolysis Induced by Paliperidone Palmitate: A Rare Adverse Effect
por: Allena, Nishant, et al.
Publicado: (2022)

Recombinant zoster vaccine (Shingrix(®)): a new option for the prevention of herpes zoster and postherpetic neuralgia
por: Singh, Grisuna, et al.
Publicado: (2020)

Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review
por: Giannelos, Nikolaos, et al.
Publicado: (2023)

The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine
por: Dagnew, Alemnew F, et al.
Publicado: (2020)

Multisystem thromboembolism in a COVID-19 patient: a case report
por: Baghal, Moaaz, et al.
Publicado: (2021)

A Rare Complication of Herpes Zoster: Segmental Zoster Paresis
por: Patel, Keshav R, et al.
Publicado: (2022)

4. Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Adults
por: Dagnew, Alemnew F, et al.
Publicado: (2020)

A Broad Safety Assessment of the Recombinant Herpes Zoster Vaccine
por: Yih, W Katherine, et al.
Publicado: (2022)

Multidisciplinary model for administration of recombinant Zoster vaccine in fragile patients
por: Martinelli, S, et al.
Publicado: (2023)

Recombinant varicella zoster virus glycoprotein E antigen vaccine for prevention of herpes zoster and postherpetic neuralgia
Publicado: (2021)

Stevens-Johnson Syndrome–Like Reaction After Exposure to Pembrolizumab and Recombinant Zoster Vaccine in a Patient With Metastatic Lung Cancer
por: Riano, Ivy, et al.
Publicado: (2020)

A Rare Case of Hypothyroidism-Induced Rhabdomyolysis
por: Syed, Omar Z, et al.
Publicado: (2023)

Increased Production of Inflammatory Cytokines after Inoculation with Recombinant Zoster Vaccine in Mice
por: Nakayama, Tetsuo, et al.
Publicado: (2022)

Reactivation of Herpes Zoster After Recombinant Vaccine (Shingrix): A Case Report
por: Altukhaim, Feras, et al.
Publicado: (2023)

A Rare Case of Rhabdomyolysis
por: Pombo, Francisco, et al.
Publicado: (2022)

A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin
por: Grosso, Federica, et al.
Publicado: (2012)

An unexpected and devastating adverse event of dasatinib: Rhabdomyolysis
por: Uz, Burak, et al.
Publicado: (2015)

Severe Cutaneous Adverse Reaction Caused by Carbamazepine and Levofloxacin After Varicella Zoster Virus Infection
por: Wang, Meifang, et al.
Publicado: (2023)

Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live
por: Curran, Desmond, et al.
Publicado: (2019)

Cost-effectiveness of the recombinant zoster vaccine in the German population aged ≥60 years old
por: Van Oorschot, Desirée, et al.
Publicado: (2018)

Recombinant Varicella-Zoster Virus Vaccines as Platforms for Expression of Foreign Antigens
por: Gray, Wayne L.
Publicado: (2013)

Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
por: Tavares-Da-Silva, Fernanda, et al.
Publicado: (2020)

Survey of Physician Practices, Attitudes, and Knowledge Regarding Recombinant Zoster Vaccine
por: Hurley, Laura P., et al.
Publicado: (2022)

Utility of a Laboratory Alert System for Detecting Adverse Drug Reactions in Hospitalised Patients: Hyponatremia and Rhabdomyolysis
por: Valdés-Garicano, Mónica, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_46ibksaaqk1m8plpvij5upsc1b